Valproic Acid–Induced Parkinsonism in the Elderly: A Comprehensive Review of the Literature (original) (raw)
Valproate-Associated Parkinsonism: A Critical Review of the Literature
Frank Besag
CNS Drugs, 2016
View PDFchevron_right
Reversible valproic acid-induced parkinsonism and cognitive impairment in an elderly patient with Bipolar Disorder I
Sameer Hassamal
Turkish Journal of Psychiatry, 2015
View PDFchevron_right
Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia
Michael silver
Parkinsonism & Related Disorders, 2013
View PDFchevron_right
The Frequency of Reversible Parkinsonism and Cognitive Decline Associated with Valproate Treatment: A Study of 364 Patients with Different Types of Epilepsy
Nikola Vojvodic
Epilepsia, 2006
View PDFchevron_right
Valproate-induced Parkinsonism in epilepsy patients
Shih-hui Lim
Movement Disorders, 2007
View PDFchevron_right
Reversible dementia and apparent brain atrophy during valproate therapy
Michael Duchowny, Oscar Papazian
Annals of Neurology, 1995
View PDFchevron_right
Validity and reliability of the Simpson-Angus Scale (SAS) in drug induced parkinsonism in the elderly
Carolina Keijsers
International Journal of Geriatric Psychiatry, 2009
View PDFchevron_right
Is valproate encephalopathy under-recognised in older people? A case series
N. Diederich
Age and Ageing, 2007
View PDFchevron_right
Reversible Rapidly Progressive Dementia with Parkinsonism Induced by Valproate in a Patient with Systemic Lupus Erythematosus
Daan Hollander
Journal of the American Geriatrics Society, 2010
View PDFchevron_right
Drug-Induced Parkinsonism in the Aged
Oscar Gershanik
Drugs & Aging, 1994
View PDFchevron_right
Systematic Evaluation of Rating Scales for Drug-Induced Parkinsonism and Recommendations for Future Research
Carolina Keijsers
Journal of Clinical Psychopharmacology, 2010
View PDFchevron_right
Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy
Andrea Botturi
Case Reports in Neurology, 2016
View PDFchevron_right
Valproic acid- induced early diagnosed encephalopathy
Recep Demir
Journal of Experimental and Clinical Medicine, 2014
View PDFchevron_right
Multiple system atrophy due to prolonged valproic acid treatment
Anna Rosati
International Psychogeriatrics, 2007
View PDFchevron_right
Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
Emmanuelle Bondon-guitton
Movement Disorders, 2011
View PDFchevron_right
Valproic acid-induced abnormal behavior
Madhan Ramesh
Indian Journal of Psychiatry, 2010
View PDFchevron_right
Dual Nature of the Antiepileptic Drug Valproic Acid, With Possible Beneficial Effects in Alzheimer’s Disease
Kristina Dominko
2017
View PDFchevron_right
Reversible cortical atrophy and cognitive decline induced by valproic acid
N. Gadoth
European Journal of Paediatric Neurology, 1998
View PDFchevron_right
Valproic acid induced encephalopathy – 19 new cases in Germany from 1994 to 2003 – A side effect associated to VPA-therapy not only in young children
Geert Mayer
Seizure, 2006
View PDFchevron_right
Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic
shimelis girma
PLOS ONE
View PDFchevron_right
Valproic Acid-Induced Hyperammonemia in the Elderly: A Review of the Literature
Rajesh Tampi
Case Reports in Medicine, 2009
View PDFchevron_right
Valproate-Induced Hyperammonemia as a Cause of Altered Mental Status
Kenneth Chuang
The American Journal of Geriatric Psychiatry, 2002
View PDFchevron_right
Valproic acid neuroprotection in 6-OHDA lesioned rat, a model for parkinson’s disease
Herbert Publications
View PDFchevron_right
Effect of valproic acid on dementia onset in patients with bipolar disorder
I-chao Liu
Journal of affective disorders, 2016
View PDFchevron_right
Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson’s Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties
Gerly Anne C. Brito
Journal of Neurodegenerative Diseases, 2015
View PDFchevron_right
Therapeutic and Toxic Effects of Valproic Acid Metabolites
Mustafa Al-zamil
Metabolites
View PDFchevron_right
Serum concentrations of valproic acid in people with epilepsy: Clinical implication
Journal Pharmacy Pharmacognosy Res JPPRes
Journal of Pharmacy & Pharmacognosy Research, 2022
View PDFchevron_right
Drug-induced parkinsonism: prevalence, clinical features and follow-up study in three Sicilian communities
Giuseppe Salemi
Journal of Neurology, 1996
View PDFchevron_right
Adverse Reactions to Antipsychotics in Parkinson Disease
carmelo aguirre
Clinical Neuropharmacology, 2015
View PDFchevron_right